Anvesana Email Formats

Biotechnology Research • Manhattan, New York, United States • 1-10 Employees

Key Contact at Anvesana

Eric Ekland

Chief Executive Officer

Company overview

Headquarters	430 E. 29th St. Floor 14, New York, NY 10016, US
NAICS	541714
Founded	2019
Employees	1-10
Socials

About Anvesana

Anvesana is developing therapeutics that increase the expression of specific proteins in order to treat disease. Insufficient protein production is the root cause of many rare genetic disorders and can exacerbate symptoms in larger more genetically complex diseases. Our core technology consists of an RNA-sequence analysis pipeline developed in the laboratory of Dr. Thomas Tuschl, cofounder of Alnylam Pharmaceuticals. Our platform queries mRNA sequence data to identify targetable regions for up-regulating gene expression using anti-sense oligonucleotides.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Anvesana has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Anvesana's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-05	3	$250,000

Funding Insights

$250,000

Total funding amount

$250,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Anvesana is located in Manhattan, New York, US.

Anvesana was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Anvesana has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Anvesana has raised a total of $250,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Anvesana

Eric Ekland

Chief Executive Officer

4.8

40,000 users